180 related articles for article (PubMed ID: 26030244)
21. New and emerging syndromes due to neuroendocrine tumors.
Vinik AI; Gonzales MR
Endocrinol Metab Clin North Am; 2011 Mar; 40(1):19-63, vii. PubMed ID: 21349410
[TBL] [Abstract][Full Text] [Related]
22. Phosphohistone H3 and Ki-67 labeling indices in cytologic specimens from well-differentiated neuroendocrine tumors of the gastrointestinal tract and pancreas: a comparative analysis using automated image cytometry.
Fung AD; Cohen C; Kavuri S; Lawson D; Gao X; Reid MD
Acta Cytol; 2013; 57(5):501-8. PubMed ID: 24021213
[TBL] [Abstract][Full Text] [Related]
23. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.
Rindi G; Klöppel G; Alhman H; Caplin M; Couvelard A; de Herder WW; Erikssson B; Falchetti A; Falconi M; Komminoth P; Körner M; Lopes JM; McNicol AM; Nilsson O; Perren A; Scarpa A; Scoazec JY; Wiedenmann B; ;
Virchows Arch; 2006 Oct; 449(4):395-401. PubMed ID: 16967267
[TBL] [Abstract][Full Text] [Related]
24. Expression of synaptic vesicle protein 2 (SV2) in neuroendocrine tumours of the gastrointestinal tract and pancreas.
Jakobsen AM; Ahlman H; Wängberg B; Kölby L; Bengtsson M; Nilsson O
J Pathol; 2002 Jan; 196(1):44-50. PubMed ID: 11748641
[TBL] [Abstract][Full Text] [Related]
25. [Gastrointestinal neuroendocrine tumors: pleomorphic and often ignored].
Maillard MH; Hiroz P; Wagner D; Prior J; Boubaker A; Pralong F; Dorta G; Nichita C
Rev Med Suisse; 2012 Sep; 8(352):1658-63. PubMed ID: 22988725
[TBL] [Abstract][Full Text] [Related]
26. Nuclear survivin is a powerful novel prognostic marker in gastroenteropancreatic neuroendocrine tumor disease.
Grabowski P; Griss S; Arnold CN; Hörsch D; Göke R; Arnold R; Heine B; Stein H; Zeitz M; Scherübl H
Neuroendocrinology; 2005; 81(1):1-9. PubMed ID: 15809513
[TBL] [Abstract][Full Text] [Related]
27. Somatostatin-receptor mediated diagnosis and treatment in gastrointestinal neuroendocrine tumours (GEP-NET's).
Oberg K
Rocz Akad Med Bialymst; 2005; 50():62-8. PubMed ID: 16358941
[No Abstract] [Full Text] [Related]
28. Grading of neuroendocrine tumors with Ki-67 requires high-quality assessment practices.
Remes SM; Tuominen VJ; Helin H; Isola J; Arola J
Am J Surg Pathol; 2012 Sep; 36(9):1359-63. PubMed ID: 22895268
[TBL] [Abstract][Full Text] [Related]
29. Clinical course of neuroendocrine tumors with different origins (the pancreas, gastrointestinal tract, and lung).
Kim SJ; Kim JW; Oh DY; Han SW; Lee SH; Kim DW; Im SA; Kim TY; Heo DS; Bang YJ
Am J Clin Oncol; 2012 Dec; 35(6):549-56. PubMed ID: 21659833
[TBL] [Abstract][Full Text] [Related]
30. Cocaine- and amphetamine-regulated transcript in neuroendocrine tumors.
Landerholm K; Falkmer SE; Järhult J; Sundler F; Wierup N
Neuroendocrinology; 2011; 94(3):228-36. PubMed ID: 21832817
[TBL] [Abstract][Full Text] [Related]
31. Current knowledge on diagnosis and staging of neuroendocrine tumors.
Oberg K; Castellano D
Cancer Metastasis Rev; 2011 Mar; 30 Suppl 1():3-7. PubMed ID: 21311954
[TBL] [Abstract][Full Text] [Related]
32. [Neuroendocrine tumors of gastrointestinal tract: the paradigm that lasts].
Bjelović MM; Babić TD
Acta Chir Iugosl; 2013; 60(1):39-45. PubMed ID: 24669561
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis and management of gastrointestinal neuroendocrine tumors.
Modlin IM; Basson MD; Mani S
Gastroenterologist; 1993 Mar; 1(1):59-70. PubMed ID: 8049881
[TBL] [Abstract][Full Text] [Related]
34. Clinical and prognostic features of rectal neuroendocrine tumors.
Weinstock B; Ward SC; Harpaz N; Warner RR; Itzkowitz S; Kim MK
Neuroendocrinology; 2013; 98(3):180-7. PubMed ID: 24080744
[TBL] [Abstract][Full Text] [Related]
35. Chromogranin A as an alternative to 5-hydroxyindoleacetic acid in the evaluation of symptoms during treatment of patients with neuroendocrine Tumors.
Korse CM; Bonfrer JM; Aaronson NK; Hart AA; Taal BG
Neuroendocrinology; 2009; 89(3):296-301. PubMed ID: 18840995
[TBL] [Abstract][Full Text] [Related]
36. Neuroendocrine tumor disease: an evolving landscape.
Frilling A; Akerström G; Falconi M; Pavel M; Ramos J; Kidd M; Modlin IM
Endocr Relat Cancer; 2012 Oct; 19(5):R163-85. PubMed ID: 22645227
[TBL] [Abstract][Full Text] [Related]
37. Histopathology of Neuroendocrine Neoplasms of the Gastrointestinal System.
Kristína MK; Pavol J; Andrea J; Zuzana Č
Klin Onkol; 2018; 31(3):167-177. PubMed ID: 30441969
[TBL] [Abstract][Full Text] [Related]
38. [Incidence, pathology and clinical course and symptoms of neuroendocrine gastrointestinal tumours].
Federspiel BH; Hansen CP; Vainer B; Hasselby JP; Bardram L; Knigge U
Ugeskr Laeger; 2010 Oct; 172(43):2946-50. PubMed ID: 21040672
[TBL] [Abstract][Full Text] [Related]
39. [Neuroendocrine tumors of the gastrointestinal tract--diagnosis and therapy].
Scherübl H; Faiss S; Zeitz M
Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S81-3. PubMed ID: 12817330
[No Abstract] [Full Text] [Related]
40. Site- and grade-specific diversity of LINE1 methylation pattern in gastroenteropancreatic neuroendocrine tumours.
Stricker I; Tzivras D; Nambiar S; Wulf J; Liffers ST; Vogt M; Verdoodt B; Tannapfel A; Mirmohammadsadegh A
Anticancer Res; 2012 Sep; 32(9):3699-706. PubMed ID: 22993308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]